Finally, while the authors mention the possibility in the Discussion, they never experimentally test whether haploinsufficiency of Zbtb20 (in the heterozygotes) would potentiate the pathology of other AD transgenes. The gene discussed is ZBTB20; the disease is Alzheimer disease.